Comprehensive serial risk assessment in pulmonary arterial hypertension has shown to
determine prognosis, monitor disease progression, and guide treatment decisions. The …

Performing longitudinal and consistent risk assessments for patients with pulmonary arterial
hypertension (PAH) is important to help guide treatment decisions to achieve early on and …

Pulmonary arterial hypertension (PAH) is a chronically progressive fatal disease. A goal‐
oriented approach to achieve low risk status has been associated with improved survival. A …

Introduction Current guidelines for the management of pulmonary arterial hypertension
(PAH) recommend regular multi-parametric assessment of a patient's risk of clinical …

Background The practice guidelines recommend that treatment decisions in Pulmonary
Arterial Hypertension (PAH) be guided by episodic assessments of patients' mortality risk …

Abstract Purpose of Review Pulmonary arterial hypertension (PAH) is a chronic,
progressive, and incurable disease with significant morbidity and mortality. Despite …

Background Achievement of low-risk status is a treatment goal in pulmonary arterial
hypertension (PAH). Risk assessment often is performed using multiparameter tools, such …

Background: Pulmonary arterial hypertension (PAH) is associated with significant morbidity
and reduced life expectancy. Various medical therapies, together with non-medical …

Background Pulmonary arterial hypertension is a progressive, fatal disease. Published
treatment guidelines recommend treatment escalation on the basis of regular patient …

Background Pulmonary arterial hypertension (PAH) prognosis has improved with targeted
therapies; however, the long-term outlook remains poor. Objective multiparametric risk …